Seguir
David Daikh
David Daikh
Afiliación desconocida
Dirección de correo verificada de ucsf.edu
Título
Citado por
Citado por
Año
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ...
Arthritis & rheumatology 71 (9), 1400-1412, 2019
26532019
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
M Aringer, C K
Arthritis and Rheumatism 71 (9), 2019
26532019
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
BH Hahn, MA Mcmahon, A Wilkinson, WD Wallace, DI Daikh, ...
Arthritis care & research 64 (6), 797-808, 2012
17192012
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
BW Kinder, HR Collard, L Koth, DI Daikh, PJ Wolters, B Elicker, KD Jones, ...
American journal of respiratory and critical care medicine 176 (7), 691-697, 2007
4562007
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
HR Schumacher Jr, JA Boice, DI Daikh, S Mukhopadhyay, K Malmstrom, ...
Bmj 324 (7352), 1488-1492, 2002
3562002
An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity
R Majeti, Z Xu, TG Parslow, JL Olson, DI Daikh, N Killeen, A Weiss
Cell 103 (7), 1059-1070, 2000
3132000
Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells
KJ Scalapino, Q Tang, JA Bluestone, ML Bonyhadi, DI Daikh
The Journal of Immunology 177 (3), 1451-1459, 2006
3102006
Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways.
DI Daikh, BK Finck, PS Linsley, D Hollenbaugh, D Wofsy
Journal of immunology (Baltimore, Md.: 1950) 159 (7), 3104-3108, 1997
2741997
Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
DI Daikh, D Wofsy
The Journal of Immunology 166 (5), 2913-2916, 2001
2512001
Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study
ACCESS Trial Group
Arthritis & Rheumatology 66 (11), 3096-3104, 2014
2352014
CTLA‐4: a key regulatory point in the control of autoimmune disease
KJ Scalapino, DI Daikh
Immunological reviews 223 (1), 143-155, 2008
2262008
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
FR Bahjat, PR Pine, A Reitsma, G Cassafer, M Baluom, S Grillo, B Chang, ...
Arthritis & Rheumatism 58 (5), 1433-1444, 2008
2002008
A randomized trial of stress management for the prevention of new brain lesions in MS
DC Mohr, J Lovera, T Brown, B Cohen, T Neylan, R Henry, J Siddique, ...
Neurology 79 (5), 412-419, 2012
1842012
Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta‐regression of diagnostic data
N Leuchten, A Hoyer, R Brinks, M Schoels, M Schneider, J Smolen, ...
Arthritis care & research 70 (3), 428-438, 2018
1672018
Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis
G Cunnane, M Warnock, KH Fye, DI Daikh
Arthritis Care & Research 47 (4), 445-449, 2002
1342002
Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration
SK Tedeschi, SR Johnson, D Boumpas, D Daikh, T Dörner, D Jayne, ...
Arthritis care & research 70 (4), 571-581, 2018
1242018
Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question
J Yazdany, G Schmajuk, M Robbins, D Daikh, A Beall, E Yelin, J Barton, ...
Arthritis care & research 65 (3), 329-339, 2013
1122013
Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years
CM Neuwelt, DI Daikh, JA Linfoot, DA Pfister, RG Young, RL Webb, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
1021997
Common language description of the term rheumatic and musculoskeletal diseases (RMD s) for use in communication with the lay public, healthcare providers, and other …
D Van Der Heijde, DI Daikh, N Betteridge, GR Burmester, AL Hassett, ...
Arthritis & rheumatology 70 (6), 826-831, 2018
932018
Common language description of the term rheumatic and musculoskeletal diseases (RMD s) for use in communication with the lay public, healthcare providers, and other …
D Van Der Heijde, DI Daikh, N Betteridge, GR Burmester, AL Hassett, ...
Arthritis & rheumatology 70 (6), 826-831, 2018
932018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20